Author:
Matsuda Takuma,Karube Hiroyo,Aruga Atsushi
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference23 articles.
1. Matsuda T, Aruga A. Comparison of regulations for the development of oncolytic virus therapy in the United States, the European Union, and Japan. Journal of Regulatory Science. 2016;4:1–9.
2. US Food and Drug Administration. FDA approves first-of-its-kind product for the treatment of melanoma. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm469571.htm. Published October 27, 2015. Accessed August 28, 2016.
3. Chiocca EA. Oncolytic viruses. Nat Rev Cancer. 2002;2:938–950.
4. Lichty BD, Breitbach CJ, Stojdl DF, Bell JC. Going viral with cancer immunotherapy. Nat Rev Cancer. 2014;14:559–567.
5. Lawler SE, Speranza MC, Cho CF, Chiocca EA. Oncolytic viruses in cancer treatment: a review. JAMA Oncol. 2017;3:841–849.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献